Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bordetella pertussis Fimbriae Types 2 and 3 (FIM2/3) are serologically distinct fimbrial antigens expressed on the surface of Bordetella pertussis. These pili mediate attachment to host respiratory epithelial cells, facilitating colonization and persistence. They are key components of acellular pertussis vaccines, inducing protective antibody responses that block bacterial adhesion. Fim2 and Fim3 are regulated by the BvgA/S system and poly(C) tract length in their promoter regions.
Induction of neutralizing antibodies that block bacterial adhesion
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bordetella pertussis Fimbriae Types 2 and 3 (FIM2/3).